PR Newswire PharmaOriginal article
Epilepsia Open publishes results of post hoc data analysis of FINTEPLA® (fenfluramine) in patients with Lennox-Gastaut syndrome
Data ReadoutpositiveFINTEPLAPositive
AI Analysis
Summary
Epilepsia Open publishes post hoc analysis data for FDA-approved FINTEPLA (fenfluramine) in patients with Lennox-Gastaut syndrome. The drug is indicated for seizure treatment in patients aged 2 years and older.
Outcome Details
Post hoc data analysis of FINTEPLA in patients with Lennox-Gastaut syndrome published
Importance:3/10
Sentiment:
0.30
FINTEPLAfenfluramineLennox-Gastaut syndromeDravet syndromeFDA approveddata analysis
Read the original article
Published by PR Newswire Pharma on August 5, 2026 2:45 PM